NCT03622788 2025-12-17Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting16 enrolled
NCT03192397 2024-05-29Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantRoswell Park Cancer InstitutePhase 1/2 Active not recruiting35 enrolled
NCT00816413 2023-08-14Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological CancerUniversity of NebraskaPhase 1/2 Withdrawn
NCT00056966 2012-06-29Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesBaylor College of MedicinePhase 1/2 Completed24 enrolled